Table 6.
The calculated performance indices for different models and SUA for the testing group (n = 100)
| Model / Method | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | AUC |
|---|---|---|---|---|---|
| ADNEX | 88.0% | 94.0% | 93.6% | 88.7% | 0.972 |
| (76.2–94.4) | (83.8–97.9) | (82.8–97.8) | (77.4–94.7) | (0.946–0.999) | |
| LR2 | 72.0% | 98.0% | 97.3% | 77.8% | 0.969 |
| (58.3–82.5) | (89.5–99.9) | (86.2–99.9) | (66.1–86.3) | (0.936–1.0) | |
| RMI3 | 82.0% | 88.0% | 87.2% | 83.0% | 0.912 |
| (69.2–90.2) | (76.2–94.4) | (74.8–94.0) | (70.8–90.8) | (0.854–0.970) | |
| RMI4 | 84.0% | 86.0% | 85.7% | 84.3% | 0.932 |
| (71.5–91.7) | (73.8–93.0) | (73.3–92.9) | (72.0–91.8) | (0.882–0.983) | |
| SRrisk | 82% | 96.0% | 95.3% | 84.2% | 0.976 |
| (69.2–90.2) | (86.5–98.9) | (84.5–98.7) | (72.6–91.5) | (0.953–0.999) | |
| SUA | 92.0% | 94.0% | 93.9% | 92.2% | 0.930 |
| (81.2–96.8) | (83.8–97.9) | (83.5–97.9) | (81.5–96.9) | (0.880–0.981) | |
| Our model | 96.0% | 86.0% | 87.3% | 95.6% | 0.977 |
| (86.5–98.9) | (73.8–93.0) | (76.0–93.7) | (85.2–98.8) | (0.955–0.999) |
95% CI 95% confidence intervals, ADNEX, LR2, RMI3, RMI4, SRrisk abbreviations for different models (details in the text), AUC area under the curve, NPV negative predictive value, PPV positive predictive value, RMI risk of malignancy index (model), SUA subjective ultrasound assessment